[EN] CRF RECEPTOR ANTAGONISTS AND METHODS OF USE<br/>[FR] ANTAGONISTES DU RÉCEPTEUR CRF ET PROCÉDÉS D'UTILISATION
申请人:NEUROCRINE BIOSCIENCES INC
公开号:WO2021113263A1
公开(公告)日:2021-06-10
Compounds are provided herein that antagonize corticotropin-releasing factor (CRF) receptors, in particular CRF receptor 1 (CRF1), as well as related preparations, compositions and methods for treating diseases and/or disorders that would benefit from the same such as congenital adrenal hyperplasia (CAH).
本文提供了一些拮抗促肾上腺皮质激素释放因子(CRF)受体的化合物,特别是CRF受体1(CRF1),以及相关的制剂、组合物和治疗疾病和/或疾病的方法,这些疾病和/或疾病可以从中受益,如先天性肾上腺皮质增生症(CAH)。